Observational study of safety and tolerability of Levemir FlexPen (insulin detemir) in the treatment of type 1 and type 2 diabetes mellitus
Phase of Trial: Phase IV
Latest Information Update: 14 Oct 2014
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 16 Oct 2009 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.
- 16 Oct 2009 Actual patient number (3299) added as reported by ClinicalTrials.gov.
- 16 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.